Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | SVP & CCO | May 05, 2020 | May 08, 2020 |
| Organon & Co.OGN · Entity 4115 | Director | June 12, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 05, 2020 · Filed May 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,751 |
Reported balance
After 2020-05-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-05-05 · Grant · Acquired 676 · Balance 24,751 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively. F2: These shares include the following RSUs granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 604 RSUs which vest in installments of 297 on 4/27/2021 and 307 on 4/27/2022; 902 RSUs which will vest in installments of 297 on 5/3/2021, 298 on 5/3/2022 and 307 on 5/3/2023; and 676 RSUs which vest in two installments of 223 on 5/5/2022 and 5/5/2023, and one installment of 230 on 5/5/2024.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $236.36 · Expires 2030-05-05 | Direct | 5,668 |
Reported balance
After 2020-05-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-05-05 · Grant · Acquired 5,668 · Balance 5,668 F5: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 270.044 |
Reported balance
Holding disclosure · report date 2020-05-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 270.044 F4: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively.
F2: These shares include the following RSUs granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 604 RSUs which vest in installments of 297 on 4/27/2021 and 307 on 4/27/2022; 902 RSUs which will vest in installments of 297 on 5/3/2021, 298 on 5/3/2022 and 307 on 5/3/2023; and 676 RSUs which vest in two installments of 223 on 5/5/2022 and 5/5/2023, and one installment of 230 on 5/5/2024.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
F5: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively.
Organon & Co.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 81,141.129 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 17,857.143 · Balance 81,141.129 F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1. F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan. F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2: Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3: Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2016 Filed Mar 29, 2016 21:22 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 6,354 | $149.24 | $948,270.96 |
DisclosureSEC source: 0001127602-16-047738 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,108 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 408 RSUs which vest on 4/27/2016; 1,843 RSUs which vest on 10/26/2016; 716 RSUs which vest on 1/28/2017; 732 RSUs which vest in one installment of 360 on 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 268 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 02, 2016 Filed Mar 4, 2016 23:19 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-045131 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,342 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 408 RSUs which vest on 4/27/2016; 1,843 RSUs which vest on 10/26/2016; 716 RSUs which vest on 1/28/2017; 732 RSUs which vest in one installment of 360 on 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 236 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 31, 2016 Filed Feb 2, 2016 01:35 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 139 | $152.73 | $21,229.47 |
DisclosureSEC source: 0001127602-16-038854 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,611 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 408 RSUs which vest on 4/27/2016; 1,843 RSUs which vest on 10/26/2016; 716 RSUs which vest on 1/28/2017; 732 RSUs which vest in one installment of 360 on 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 236 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2016 Filed Feb 2, 2016 01:35 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 308 | $150.47 | $46,344.76 |
DisclosureSEC source: 0001127602-16-038854 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,721 Read SEC document |
| November 09, 2015 Filed Nov 12, 2015 21:45 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 633 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-031173 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,029 Read SEC document |
| October 26, 2015 Filed Oct 27, 2015 22:13 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 987 | $155.75 | $153,725.25 |
DisclosureSEC source: 0001127602-15-029628 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,662 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 408 RSUs which vest on 4/27/2016; 1,843 RSUs which vest in one installment on 10/26/2016; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 259 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| June 02, 2015 Filed Jun 3, 2015 23:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,530 | $157.06 | $711,481.80 |
DisclosureSEC source: 0001127602-15-019787 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,571 F1 · price: The price reported is an average price. The prices ranged from $154.80 to $157.97 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 408 RSUs which vest on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 282 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2015 Filed Apr 29, 2015 00:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 219 | $167.91 | $36,772.29 |
DisclosureSEC source: 0001127602-15-015479 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,101 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 408 RSUs which vest on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 282 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 25, 2015 Filed Apr 29, 2015 00:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 266 | $167.91 | $44,664.06 |
DisclosureSEC source: 0001127602-15-015479 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,320 Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 22:57 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,500 | $160.55 | $561,925.00 |
DisclosureSEC source: 0001127602-15-012984 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,586 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 508 RSUs which vest on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 304 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 04, 2015 Filed Mar 7, 2015 02:08 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 7,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-010547 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,006 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018; and 919 shares that vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 263 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 30, 2015 Filed Feb 4, 2015 00:09 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 919 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-004141 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,439 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018; and 919 RSUs which vest in two equal installments of 303 on 1/30/2017 and 1/30/2018 and one installment of 313 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 263 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:05 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 10 | $158.89 | $1,588.90 |
DisclosureSEC source: 0001127602-15-003494 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,520 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 1,410 RSUs which vest in two installments of 694 and 716 on 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 263 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:05 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 284 | $158.89 | $45,124.76 |
DisclosureSEC source: 0001127602-15-003494 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,530 Read SEC document |
| October 28, 2014 Filed Oct 29, 2014 23:55 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 522 | $148.20 | $77,360.40 |
DisclosureSEC source: 0001127602-14-030488 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,787 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 261 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 26, 2014 Filed Oct 28, 2014 20:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 35 | $147.26 | $5,154.10 |
DisclosureSEC source: 0001127602-14-030377 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,309 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,000 RSUs which fully vest on 10/28/2014; 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 3,632 RSUs which vest in two installments of 1,789 and 1,843 on 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 261 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 26, 2014 Filed Oct 28, 2014 20:06 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 933 | $147.26 | $137,393.58 |
DisclosureSEC source: 0001127602-14-030377 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,344 Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:20 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,724 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-14-024951 · form4.xml · derivative · entry 6 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,777 Underlying: Common Stock · 1,724 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:20 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 920 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-14-024951 · form4.xml · derivative · entry 5 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 920 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:20 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,644 | $127.97 | $338,357.97 |
DisclosureSEC source: 0001127602-14-024951 · form4.xml · nonDerivative · entry 3 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,234 F1 · price: The price reported is an average price. The prices ranged from $126.62 to $129.00 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,000 RSUs which fully vest on 10/28/2014; 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 284 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:20 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,724 | $54.69 | $94,285.56 |
DisclosureSEC source: 0001127602-14-024951 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2014 Filed Aug 7, 2014 20:20 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 920 | $58.43 | $53,755.60 |
DisclosureSEC source: 0001127602-14-024951 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 8 | $111.41 | $891.28 |
DisclosureSEC source: 0001127602-14-015511 · form4.xml · nonDerivative · entry 4 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,185 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,000 RSUs which fully vest on 10/28/2014; 508 RSUs which vest in on 4/25/2015; 804 RSUs which vest in two annual installments of 396 on 4/27/2015 and 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 235 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 182 | $111.41 | $20,276.62 |
DisclosureSEC source: 0001127602-14-015511 · form4.xml · nonDerivative · entry 3 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,193 Read SEC document |
| April 26, 2014 Filed Apr 29, 2014 21:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 50 | $111.41 | $5,570.50 |
DisclosureSEC source: 0001127602-14-015511 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,375 Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:56 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 186 | $113.72 | $21,151.92 |
DisclosureSEC source: 0001127602-14-015511 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,425 Read SEC document |
| March 14, 2014 Filed Mar 18, 2014 20:33 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,377 | $123.96 | $170,692.92 |
DisclosureSEC source: 0001127602-14-012038 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,611 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 1,000 RSUs which fully vest on 10/28/2014; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 249 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:39 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-010758 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,938 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 1,000 RSUs which fully vest on 10/28/2014; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 199 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 23:01 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-004390 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,275 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 1,000 RSUs which fully vest on 10/28/2014; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively; and 1,092 RSUs which vest in two equal installments of 360 on 1/31/2016 and 1/31/2017 and one installment of 372 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 199 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 28, 2013 Filed Oct 29, 2013 22:18 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 376 | $116.32 | $43,736.32 |
DisclosureSEC source: 0001127602-13-029954 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,146 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 1,000 RSUs which fully vest on 10/28/2014; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 162 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,724 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · derivative · entry 8 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,501 Underlying: Common Stock · 1,724 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 920 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · derivative · entry 7 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920 Underlying: Common Stock · 920 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 900 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · derivative · entry 6 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 900 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,544 | $105.01 | $372,148.00 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · nonDerivative · entry 4 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,442 F1 · price: The price reported is an average price. The prices ranged from $104.999 to $105.0415 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 82 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,724 | $54.69 | $94,285.56 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · nonDerivative · entry 3 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 920 | $58.43 | $53,755.60 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2013 Filed May 17, 2013 21:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 900 | $50.44 | $45,396.00 |
DisclosureSEC source: 0001127602-13-017468 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2013 Filed Apr 30, 2013 21:23 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 49 | $108.38 | $5,310.62 |
DisclosureSEC source: 0001127602-13-014781 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,442 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 82 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:23 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 50 | $108.66 | $5,433.00 |
DisclosureSEC source: 0001127602-13-014781 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,491 Read SEC document |
| April 25, 2013 Filed Apr 29, 2013 22:07 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 185 | $104.93 | $19,412.05 |
DisclosureSEC source: 0001127602-13-014709 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,541 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 82 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 15, 2013 Filed Mar 19, 2013 23:50 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 569 | $92.18 | $52,450.42 |
DisclosureSEC source: 0001127602-13-011478 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,726 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 82 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2013 Filed Mar 8, 2013 23:26 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,514 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-010163 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,251 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 38 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2013 Filed Jan 31, 2013 01:09 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-003255 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,737 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 38 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 28, 2012 Filed Oct 29, 2012 23:49 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 367 | $87.63 | $32,160.21 |
DisclosureSEC source: 0001127602-12-029207 · form4.xml · nonDerivative · entry 2 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,607 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 129 RSUs which fully vest on 4/28/2013; 263 RSUs which vest in two installments of 131 and 132 on 4/26/2013 and 4/26/2014, respectively; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,493 RSUs which vest in three installments of 492, 493 and 508 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; and 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 11 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| October 26, 2012 Filed Oct 29, 2012 23:49 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-029207 · form4.xml · nonDerivative · entry 1 Patton Cynthia M · CIK 0001560565 · SVP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,974 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 10/26/2014, 10/26/2015 and 10/26/2016, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.